Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules

Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to treat Parkinson's disease and other conditions characterized by motor function disorders. The capsules are made with Methocel E4M, a controlled-release polymer that ensures the gradual release of the active ingredients, Carbidopa and Levodopa, over an extended period of time.

This slow-release mechanism provides sustained therapeutic effects, reducing the need for frequent dosing and improving patient compliance. The formulation is particularly beneficial for patients requiring a controlled and prolonged release profile for their medication, ensuring consistent and effective management of their disease states.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
653858212e492dee41f9bad0
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

The Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to treat Parkinson's disease and other conditions related to the nervous system. This formulation uses Methocel E4M, a controlled-release polymer, to gradually release the active ingredients, Carbidopa and Levodopa, over an extended period of time. This slow-release mechanism ensures sustained therapeutic effects, reducing the need for frequent dosing and improving patient compliance.

Carbidopa and Levodopa are two active ingredients that work together to manage the symptoms of Parkinson's disease. Levodopa is converted into dopamine in the brain, helping to control movement and coordination. However, when taken alone, a large amount of Levodopa is broken down in the body before it can reach the brain. Carbidopa is added to prevent this premature breakdown of Levodopa, ensuring more of it reaches the brain to exert its therapeutic effects.

The Methocel E4M polymer used in this formulation is a key component in achieving the slow-release effect. It forms a gel-like matrix in the stomach, which gradually dissolves and releases the medication over time. This not only ensures a steady level of medication in the body but also reduces the risk of side effects that can occur with sudden, high levels of medication. This makes the Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules an effective and patient-friendly option for managing Parkinson's disease and other related conditions.

It's important to note that while this formulation can help manage the symptoms of Parkinson's disease, it does not cure the disease. Regular monitoring and dose adjustments may be necessary based on the patient's response to the medication. As with any medication, potential side effects may occur, and patients should be advised to report any unusual symptoms to their healthcare provider.

If you have any questions about the Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules, or if you need further information about this formulation, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.

Drug Interactions

A small arrow pointing down

Carbidopa/Levodopa slow-release capsules are primarily used in the treatment of Parkinson's disease and Parkinson's-like symptoms such as shakiness, stiffness, and difficulty moving. The combination of Carbidopa and Levodopa helps to control these symptoms by restoring the balance of certain natural substances (dopamine) in the brain.

It's important to be aware of potential drug interactions with Carbidopa/Levodopa slow-release capsules. Certain medications may decrease the absorption of Levodopa, affecting its efficacy. These include some products containing iron (such as iron supplements, multivitamins), antacids containing aluminum, calcium, magnesium, metoclopramide, and certain drugs used for high blood pressure (including reserpine and alpha blockers such as prazosin).

Carbidopa/Levodopa can interact with other medications that can cause drowsiness, including alcohol, antihistamines (such as cetirizine, diphenhydramine), drugs for sleep or anxiety (such as alprazolam, diazepam, zolpidem), muscle relaxants, and narcotic pain relievers (such as codeine).

MAO inhibitors (Isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine) taken alongside Carbidopa/Levodopa can increase the risk of serious side effects (such as high blood pressure, severe nausea, muscle stiffness). Therefore, it is advised to avoid MAO inhibitors during treatment with this medication.

It's also important to note that high-protein diets can decrease the absorption of Levodopa. Therefore, dietary modifications may be necessary to ensure the maximum effectiveness of this medication.

Always inform your healthcare provider about all the products you use (including prescription drugs, nonprescription drugs, and herbal products) before starting treatment with this product. Do not start, stop, or change the dosage of any medicines without your doctor's approval.

This is not a complete list of possible drug interactions. If you have any questions or concerns about the interactions of Carbidopa/Levodopa slow-release capsules with other medications or substances, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.

How Does it Work

A small arrow pointing down

The Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules work by utilizing a controlled-release polymer known as Methocel E4M. This polymer is designed to gradually release the encapsulated medication over an extended period of time. This slow release mechanism allows for sustained therapeutic effects, reducing the need for frequent dosing and improving patient compliance, particularly for medications that require a controlled and prolonged release profile.

Carbidopa and Levodopa are two active ingredients in this formulation. Levodopa is converted into dopamine in the brain, helping to control the symptoms of Parkinson's disease such as tremors, stiffness, and difficulty with movement. However, when taken alone, a large amount of Levodopa is broken down in the body before it can reach the brain. This is where Carbidopa comes in. Carbidopa inhibits the breakdown of Levodopa in the body, allowing more Levodopa to reach the brain and effectively control the symptoms of Parkinson's disease.

The Methocel E4M polymer in this formulation ensures that Carbidopa and Levodopa are released slowly and steadily into the body. This not only maintains a constant level of these medications in the body but also reduces the occurrence of side effects that are often associated with high peak levels of these medications. The slow release of these medications also means that patients do not have to take the medication as frequently, improving patient compliance.

This formulation is particularly beneficial for patients with Parkinson's disease, a neurodegenerative disorder that affects movement. The slow release of Carbidopa and Levodopa helps to control the symptoms of this disease, improving the patient's quality of life. It is also beneficial for patients with other conditions that are characterized by motor function disorders, as the slow release of these medications helps to control the symptoms of these conditions as well.

If you have any questions about the Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us. We are here to provide you with the information you need to make informed decisions about your medication.

Other Uses

A small arrow pointing down

Carbidopa and Levodopa in the Methocel E4M formulation are most commonly used for the treatment of symptoms associated with Parkinson's disease such as shakiness, stiffness, and difficulty with movement. These two drugs work hand-in-hand where Carbidopa helps increase the levels of Levodopa in the body while also reducing its side effects.

Beyond this, the Carbidopa/Levodopa slow release oral capsules can also be of therapeutic value in other motor disorders. One such example could be neurodegenerative diseases similar to Parkinson’s disease with motor symptoms, like multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration. It is important to note however, that the use of this formulation for these conditions is off-label and should only be considered under the specific instruction of a healthcare provider.

The Methocel E4M capsule preparation is particularly beneficial for patients requiring overnight control of symptoms, as it can provide a smoother and more sustained drug release, hence decreasing the possibility of early morning off episodes that are commonly experienced in advanced stages of Parkinson's disease. This extended-release formulation is especially useful for patients who have difficulty managing the frequent dosing required with immediate-release formulations and good for those who seek consistent maintenance of therapeutic drug levels.

In addition to this, Carbidopa/Levodopa slow-release capsules may also be used in other clinical scenarios that aren't related to motor disorders. For instance, research has suggested that the slow-release formulation of Levodopa could potentially be used in the treatment of restless legs syndrome, a neural disorder characterized by unpleasant sensations in the legs and an overpowering urge to move them for relief. But again, it’s elective and should be determined based on the benefit-risk ratio by a healthcare provider.

Each patient is unique and their response to a medication can vary widely, hence it is always critical to remunerate a patient’s individual condition and circumstances before initiating any therapy. Kindly note that the information given is to aid your understanding, it's not a substitute for professional medical advice. If you have any queries or concerns about this formulation's extended uses, reach out to us at Bayview Pharmacy.

Frequently Asked Questions

A small arrow pointing down

What is Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules?

Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules is a compounded medication formulated with Methocel E4M, a controlled-release polymer. The capsule is structured to release the medication gradually over a period of time, ensuring sustained therapeutic effects and improved patient compliance.

What is the function of Methocel E4M in these capsules?

Methocel E4M is a type of controlled-release polymer. It is designed to release the active medication gradually, over an extended period, to provide sustained therapeutic effects and decrease the number of doses required.

What are the benefits of slow-release capsules?

Slow-release capsules offer a number of benefits. These include sustained medicinal effects over an extended period, reduced dosing frequency, and thereby improved patient compliance, especially for medications requiring a controlled and prolonged release profile.

Do these capsules need to be taken multiple times a day?

The slow-release mechanism of this medication is designed to reduce the frequency of dosing. However, the specific dosing regimen should be prescribed by your healthcare provider based on your individual health conditions.

Are there any side-effects associated with these capsules?

As with any medication, there might be potential side-effects. If you experience any unwanted or unusual effects after taking the medication, contact your healthcare provider immediately. The specific side-effects of these capsules might vary based upon the encapsulated medication.

What is meant by improved patient compliance?

Improved patient compliance refers to the increased likelihood of patients effectively adhering to their prescribed medication regimen. This is often achieved by making the regimen simpler, such as by reducing the frequency of dosing, which is what these slow-release capsules aim to do.

Do I need a prescription for Carbidopa 50 mg/Levodopa 200 mg Slow Release (MEM4) Oral Capsules?

Yes, these capsules are a prescription medication. They should be used only as directed by a healthcare provider.

Can anyone use these slow-release capsules?

These capsules are suitable for patients to whom they are prescribed by a healthcare provider after considering their individual health condition. The use of these capsules without proper consultation may have potential risks.

Can I take these capsules with my other medications?

As with any medicine, there may be potential interactions with other medications. Always inform your healthcare provider of any other medications you are taking to ensure these capsules can be safely taken along with them.

What happens if I miss a dose of these capsules?

In case you miss a dose, take it as soon as you remember. However, if it's near the time for your next dose, skip the missed one and resume your usual schedule. You should not double up the dose to make up for the missed one. Always consult your healthcare provider for proper guidance.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.